Music festivals have become more open to harm reduction initiatives. How far will it go?
NEW YORK (AP) — The sounds of muffled percussion and audience cheers reverberate throughout the grounds. Brand activations, makeshift bars and restaurant pop-ups control traffic as a sea of bodies move from set to set. Sandwiched between is a row of nonprofits across familiar causes: hunger, housing and voter registration.
It's a common music festival scene, until closer inspection. There is a new table, This Must Be the Place. The Ohio-based nonprofit offers attendees free opioid overdose reversal treatment and training on how to use it, an education acquired in under two minutes. Just a few years ago, their inclusion might've been unthinkable amid murky regulations and a lack of public awareness surrounding harm reduction.
Advocates say drugs are commonly consumed at music festivals, making them ideal locations for harm reduction activities. While more music festivals are allowing such activities, activists are pushing for expanded efforts as some festivals remain cautious.
Harm reduction varies at festivals across the country
Founded by William Perry and Ingela Travers-Hayward in 2022, This Must Be The Place has since given away an estimated $4.5 million in naloxone, the opioid overdose reversal medication, at festivals and smaller community events.
In the very beginning, without a 'proof of concept,' as Perry describes it, they had trouble partnering with festivals. Eventually, a few festivals in the Midwest agreed to let them table, which 'got us in the door with Bonnaroo in 2022,' says Perry, referring to the major U.S. festival operated by C3 Presents, one of the largest concert promoters on the planet. Now they have a presence at 35 major U.S. festivals — including Lollapalooza, Governors Ball and Besame Mucho — where they collaborate directly with C3 and their security personnel.
The organization's growth overlaps with advancing federal regulations. According to Daliah Heller, vice president of overdose prevention initiatives at the global public health nonprofit Vital Strategies, naloxone distribution used to be determined by state regulations until 2023, when the Food and Drug Administration approved the first over-the-counter nasal spray.
'We no longer need the prescription laws to be amended to allow for the distribution of naloxone,' she says. 'Now it's like buying aspirin — it's over the counter.'
Last year, This Must Be the Place gave away 46,146 units of Narcan — a brand name for naloxone — through their national festival outreach.
Emmett Beliveau, chief operating officer of C3 Presents, says working with This Must Be the Place was C3's first time implementing public-facing harm reduction strategies, in addition to the promoter's existing medical programs.
Bringing the organization into C3's festivals was 'not in response to anything that has happened at one of our festivals,' he says, but rather because of the 'number of fatalities happening in our communities.'
Some attendees have taken matters into their own hands
Some activists believe attendees are most responsive to receiving harm reduction education from peers instead of authority figures. And so, for the last three years, a nonprofit dedicated to combating accidental drug overdoses among young adults, Team Awareness Combating Overdose, has distributed fentanyl test strips and Narcan at the Coachella Valley Music and Arts Festival.
Former TACO CEO Kameran Mody says that music festivals are ideal locations for distribution and education because 'music and the use of drugs are synonymous with each other.'
TACO distributes through what Mody describes as 'guerrilla-style marketing.' They enlist volunteers, train them on how to use naloxone, and ship Narcan and test strips to them to bring into the festival.
They do not involve the festival organizers. Representatives for Coachella did not respond to The Associated Press' requests for comment.
In 2023, a TACO volunteer administered Narcan to an unresponsive Coachella attendee exhibiting signs of an overdose. The organization says the attendee regained consciousness.
'That was one of our biggest successes,' Mody says.
Local laws and the risk of criminalization hinder initiatives
In 2019, at Bonnaroo, a 27-year-old man was found dead at his campsite — right after harm reduction activists had picketed the Tennessee festival because it didn't allow drug testing. The toxicology report found ecstasy and fentanyl in his system.
At the time, under state law, test strips were criminalized and classified as drug paraphernalia. That's changed: In 2022, Tennessee decriminalized fentanyl test strips. By the end of 2023, 44 other states and D.C. had done the same.
But in some states, drug paraphernalia laws are written in a way that isn't completely transparent — there are test strips that are not fentanyl-specific, Heller points out — and criminalization and social stigmas endure.
Some have found workarounds. 'Even in the states where the legalities were a bit unclear, instead of just coming in and hoping things worked out, we would reach out to the health department, and say 'We run this project, how do feel about it?'' says Perry. 'We would end up with letters from the highest-ranking health official, either in the county or in the state, saying 'We approve of this.' That circumvented any roadblocks.'
Some festivals, though, might be hesitant to use test strips because 'it's tough for them to admit that drugs are being used,' Mody says. Some festivals have even banned naloxone.
While This Must Be The Place distributes fentanyl test strips at some Ohio events, C3 doesn't distribute test strips at its events and does not plan to. Beliveau doesn't believe fentanyl test strips are effective and expressed concern they could encourage drug use. Test strips, which can detect fentanyl in pills, powders or injectables, are recommended by the Centers for Disease Control and Prevention as a low-cost means of helping prevent drug overdoses.
Harm reduction shows promise outside the US
At a three-day electronic music festival in Mexico City earlier this year, a booth provided free, anonymous drug testing. The initiative, known as 'Checa tu Sustancia' (Check Your Substance), was spearheaded by the Instituto RIA, a Mexico-based drug policy research and advocacy organization.
When unexpected substances are detected, users received detailed information on what they are, their risks, potential interactions with other substances and dosage adjustments, empowering them to make informed choices.
Perry says they are aware of smaller festivals in the United States conducting drug checking, but 'they do it in a very underground and whisper network way' to avoid criminalization.
What Perry says his organization would like to see at music festivals in the future would be harm reduction areas — sections where attendees who have taken drugs can be monitored, not to 'get them into trouble' but to ensure safety.
Heller says there are a number of groups working to destigmatize drugs, promote decriminalization, and promote drug checking.
'We already have drug checking happening in cities,' she says. 'It makes perfect sense to expand the settings where you would offer that to include music festivals. It's the same rationale. ... The issue is this idea of liability. You'd have to create a law, essentially, that would protect the festival from liability.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Montana Supreme Court strikes down trio of abortion bills as unconstitutional
In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland. A Massachusetts appeals court temporarily blocked a Texas-based federal judge's ruling that suspended the FDA's approval of the abortion drug Mifepristone, which is part of a two-drug regimen to induce an abortion in the first trimester of pregnancy in combination with the drug Misoprostol. (Photo illustration by) A trio of abortion-related bills, passed in 2021, were declared unconstitutional by a nearly unanimous Montana Supreme Court on Monday. Nearly, because Justice Jim Rice wrote both a concurring and dissenting opinion affirming again Montana's constitutionally protected right-to-privacy, which includes medical procedures and abortion. The laws were halted before they could even be practically enacted, so the hurdles to the procedure, including waiting periods, mandatory ultrasound, a pile of documentation and banning abortion after 20 weeks, even before the point of fetal viability, never rippled throughout the state. Justice Beth Baker wrote the opinion on behalf of the court, which not only reaffirmed the state Constitution's right-to-privacy as unique and separate from federal cases on abortion, but also took the state to task for failing to support its claim that the State of Montana had a compelling interest in abortion, while not proving that any of the legislative hurdles were scientifically supported. The lawsuit was brought by Planned Parenthood of Montana, and had a handful of other entities that wrote friends-of-the-court briefs, including a group of delegates to the 1972 Montana Constitutional Convention. The three laws that were challenged were House Bill 136, House Bill 140 and House Bill 171: HB 136 would have banned abortion at 20 weeks, even though expert opinion agreed that fetal viability is not possible until at least 22 weeks. HB 171 would have put paperwork and more requirements for healthcare providers who provide abortion via medication or telehealth, subjecting them to both civil and criminal penalties. HB 180 would have required healthcare professionals to provide both ultrasound and fetal heartbeat tones to those considering abortion, and requiring a patient to sign a form created by the state, demonstrating that the patient had been offered the choice, and yet declined. Because fetal viability — or the concept a child can survive outside the womb — is dictated by a host of factors, including medical science and approximate age of the fetus, the court rejected the state's attempts to prescribe a fixed number of weeks for viability. 'A fixed gestational age that does not allow a provider's case-specific determination fails to ensure that the government does not interfere with an individual's private medical decision,' the ruling said. 'Until a fetus is viable and able to survive outside the womb, the right of personal autonomy belongs to the person on whose body the fetus depends. 'We find no legal authority for the idea that the state's interest in preserving fetal life or the fetus' right to life takes precedence over all constitutional protections and dignities of the mother.' Attorneys for the state had argued that physical safety risks of abortion increase as the pregnancy progresses, and that abortions lead to worse mental health outcomes, an argument that the Supreme Court dismissed and debunked. 'The record shows that abortion is safe,' the decision said. 'As the district court noted, there were zero deaths cause by abortion in Montana between 2010 and 2020 and only 25 of 8,402 (0.3%) reported abortions in Montana from 2016 to 2021 resulted in complications. This court cannot find a bona fide health risk simply based on a detailed step-by-step description of what the state defines as 'barbaric' and 'gruesome' procedure when the overwhelming evidence shows that procedural abortions are safe.' The ruling also said if the state wanted to address health outcomes or mental health issues, banning abortion was not the least restrictive way to do it. The court also pointed out waiting-periods and requiring multiple in-person visits, as outlined by HB 171, actually increased the odds of harm or complications, instead of avoiding them. 'The record demonstrates that compliance with the 24-hour wait period, the multiple in-person visits, and the telehealth ban serve only to delay access to abortion care — thus increasing the odds that the patient will not be able to obtain an abortion or increasing the odds of the very complications this state asserts it wishes to protect against,' the opinion said. The ruling also said in addition to violating the state's constitutional provisions for privacy, it also impacted physician's free-speech rights by requiring them to provide forms and documents, for example, information about a disputed abortion reversal procedure, that have not been medically verified or supported. They said HB 171 compelled healthcare professionals to give advice contrary to their training and conscience. Physicians and experts also raised concerns about the state's assertion abortion led to other health care concerns, for example, an increase in breast cancer, which has never been scientifically established. 'Forcing medical providers to give medical advice that they disagree with — like the safety and efficacy of abortion reversal — is a form of compelled-speech triggering protections,' the ruling said. '(Planned Parenthood) asserts that patients may mistakenly understand the consent form to indicate DPHHS's and their provider's approval of abortion reversal.' The ruling calls such compelled speech egregious because it 'favors one viewpoint over another — namely, the viewpoint that abortion reversal is safe and possible over the judgements and viewpoints of providers that it is unsafe, ineffective and undermines informed consent.' The court noted the state does not mandate documentation or consent that requires medical providers to discuss the risk of carrying a pregnancy to term. Finally, the court also called into question the real purpose of HB 140, which mandates ultrasounds and fetal heart tones before an abortion, something that providers said either happens during the course of pregnancy, but may not be medically necessary. 'The court stated it was 'left with the strong impression that the law aims to advance the ulterior motive of discouraging abortion,' which is unacceptable under the law,' the ruling said. Montana's highest court found that in the case of HB 140, it was exactly substituting the judgment of the state, and the lawmakers who supported it, with the views of the doctor. 'The court's decision further protects what Montanans need and deserve: Legal access to compassionate, timely abortion care, free from government interference. At the same moment as this win for Montanans, anti-abortion politicians continue to threaten to decimate access to care by 'defunding' Planned Parenthood via the reconciliation bill before Congress, in an effort to shut down health centers who provide abortion and other reproductive care. Montanans agree that abortion should remain legal and accessible, and Planned Parenthood of Montana will always do whatever we can to ensure that patients in Montana have access to abortion care,' said Martha Fuller, president and CEO of Montana Planned Parenthood, after the ruling in a statement. The case was active for several years of litigation, and had district court Judge Amy Eddy sitting in place of former Chief Justice Mike McGrath, who retired at the end of 2024, as well as Judge Shane Vannatta, who was sitting in for Dirk Sandefur, who also retired. McGrath has since been replaced by Chief Justice Cory Swanson, and Sandefur was succeeded by Justice Katherine Bidegaray.
Yahoo
an hour ago
- Yahoo
8 ice cream flavors recalled in Ohio
WAUSEON, Ohio — An Ohio-based creamery has announced a voluntary recall due to undeclared allergens in eight of their ice cream flavors. According to the Ohio Department of Agriculture, Turkeyfoot Creek Creamery of Wauseon, Ohio, is recalling the following flavors of ice cream; Avalanche, Chocolate Peanut Butter, Chocolate Strawberry, Chocolate Brownie Bites, Cookies and Cream, Cookie Dough, Cacao and Mocha. Massive egg recall hits Ohio Walmart stores The affected products are all packaged in pint containers and were distributed to six stores, located in Canton, Cleveland, West Unity, and Arlington, Ohio. As well, as two stores located out of state, with one in Fort Wayne, Indiana, and the other in Hudson, Michigan, read a press release from the Ohio Department of Agriculture. Young mother killed in shooting at Cleveland Metroparks Mill Creek Falls 'There have been no reports of illness involving products addressed in this recall, however, individuals exhibiting signs or symptoms of an allergic reaction after consuming Turkeyfoot Creek Creamery Ice Cream involved in this recall should contact a physician immediately,' stated the release. All affected products have been removed from store shelves. Consumers can return recalled products to the place of purchase for a refund. Consumers with questions can call 419-583-7124. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Topeka's KMC Dermatology Is First in Kansas to Offer Nonsurgical GentleCure™ Treatment Option for Common Skin Cancer
BURR RIDGE, Ill., June 11, 2025 /PRNewswire/ -- SkinCure Oncology, the industry leader in providing a comprehensive cancer center model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer (NMSC), presented to dermatology patients and professionals as the GentleCure Experience™, today announced its first availability in Kansas at an event at Topeka's KMC Dermatology. Image-Guided SRT is the only treatment for nonmelanoma skin cancer (basal and squamous cell carcinoma) that uses ultrasound imaging to help clinicians direct low-level x-rays to targeted areas of the skin, killing cancer cells. For patients treated with Image-Guided SRT, the cure rate (freedom from recurrence at six years) has been shown to be greater than 99 percent, with researchers reporting that for appropriately selected early-stage nonmelanoma skin cancers, Image-Guided SRT is a clinically equivalent alternative to Mohs surgery and statistically significant in superiority to non-Image-Guided SRT. Dr. Joseph Gadzia of KMC Derm noted, "More than 26,000 individuals in Kansas are expected to be diagnosed with nonmelanoma skin cancer this year. We know that sun exposure is the main cause of this type of cancer but there are other factors as well. For those who have been diagnosed with nonmelanoma skin cancer, we now offer a nonsurgical treatment option which we call the GentleCure Experience, and we are proud to be the first practice in the state to offer it." Dr. Gadzia also added, "While most common skin cancers have been treated with Mohs surgery, this newer treatment option achieves close to the same success rate with no surgery, no surgical scarring, and no bleeding. As of this past April, more than 100,000 patients have been successfully treated with Image-Guided SRT in the United States." Other speakers included Dr. Shekhar Challa; U.S. Senator Roger Marshall via video; Topeka Mayor Michael Padilla; Aaron Mays, Chairman of the Shawnee County Board of Commissioners; and John Mugler, District Director, Office of Senator Marshall. In addition, Kansas Governor Laura Kelly issued a gubernatorial proclamation declaring June 8 – 14 "Kansas Nonmelanoma Skin Cancer Awareness Week," noting that KMC Dermatology is the first practice in the state of Kansas to offer Image-Guided SRT. Kerwin Brandt, chief executive officer of Chicago-based SkinCure Oncology, said, "We are delighted to partner with KMC Dermatology to offer this highly effective, noninvasive treatment option for their patients. It is critical that patients everywhere have the choice of treating their nonmelanoma skin cancer without surgery." About SkinCure OncologySkinCure Oncology is the industry leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT), the most advanced nonsurgical treatment for common skin cancer. The company partners with quality-focused dermatologists, Mohs surgeons and other physicians to bring cancer center-level radiation therapy treatment to private practices. Presented to patients as the GentleCure Experience™, Image-Guided SRT is available from some 500 physicians nationwide, with more than 100,000 patients having been treated. Learn more about the company at and visit for helpful consumer and patient information. Media Contact:Matt RussellRussell Public Communications520-232-9840mrussell@ View original content to download multimedia: SOURCE SkinCure Oncology Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data